Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review
- PMID: 32760219
- PMCID: PMC7392660
- DOI: 10.1186/s12935-020-01439-w
Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review
Abstract
Background: anaplastic thyroid cancer (ATC) is one of the most lethal and aggressive cancers. Evidence has shown that the tumorigenesis of ATC is a multistep process involving the accumulation of genetic and epigenetic changes. Several studies have suggested that long non-coding RNAs (lncRNAs) may play an important role in the development and progression of ATC. In this article, we have collected the published reports about the role of lncRNAs in ATC.
Methods: "Scopus", "Web of Science", "PubMed", "Embase", etc. were systematically searched for articles published since 1990 to 2020 in English language, using the predefined keywords.
Results: 961 papers were reviewed and finally 33 papers which fulfilled the inclusion and exclusion criteria were selected. Based on this systematic review, among a lot of evidences on examining the function of lncRNAs in thyroid cancer, there are only a small number of studies about the role of lncRNAs and their molecular mechanisms in the pathogenesis of ATC.
Conclusions: lncRNAs play a crucial role in regulation of different processes involved in the development and progression of ATC. Currently, just a few lncRNAs have been identified in ATC that may serve as prognosis markers such as GAS5, MIR22HG, and CASC2. Also, because of the dysregulation of Klhl14-AS, HOTAIRM1, and PCA3 during ATC development and progression, they may act as therapeutic targets. However, for most lncRNAs, only a single experiment has evaluated the expression profile in ATC tissues/cells. Therefore, further functional studies and expression profiling is needed to resolve this limitation and identify novel and valid biomarkers.
Keywords: Anaplastic thyroid cancer; Cancer stem cell; Long non-coding RNA; Oncogene; Systematic review; Tumor suppressor.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare that they have no conflict of interest.
Figures
Similar articles
-
Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.Endocr Pathol. 2019 Dec;30(4):262-269. doi: 10.1007/s12022-019-09589-y. Endocr Pathol. 2019. PMID: 31468286
-
Roles of Non-Coding RNAs on Anaplastic Thyroid Carcinomas.Cancers (Basel). 2020 Oct 28;12(11):3159. doi: 10.3390/cancers12113159. Cancers (Basel). 2020. PMID: 33126409 Free PMC article. Review.
-
Mitotically associated long non-coding RNA is a tumor promoter in anaplastic thyroid cancer.Ann Transl Med. 2020 Oct;8(19):1226. doi: 10.21037/atm-20-4530. Ann Transl Med. 2020. PMID: 33178758 Free PMC article.
-
The Role of ATP-Binding Cassette Transporters in the Chemoresistance of Anaplastic Thyroid Cancer: A Systematic Review.Endocrinology. 2019 Aug 1;160(8):2015-2023. doi: 10.1210/en.2019-00241. Endocrinology. 2019. PMID: 31271419
-
Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.Daru. 2019 Jun;27(1):1-7. doi: 10.1007/s40199-018-0231-3. Epub 2019 May 10. Daru. 2019. PMID: 31077090 Free PMC article.
Cited by
-
Use of long non-coding RNAs for the molecular diagnosis of papillary thyroid cancer.Front Oncol. 2022 Sep 5;12:924409. doi: 10.3389/fonc.2022.924409. eCollection 2022. Front Oncol. 2022. PMID: 36132147 Free PMC article.
-
Targeting Long Non-Coding RNA TTN-AS1 Suppresses Bladder Cancer Progression.Front Genet. 2021 Oct 4;12:704712. doi: 10.3389/fgene.2021.704712. eCollection 2021. Front Genet. 2021. PMID: 34671381 Free PMC article.
-
Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis.Oncol Lett. 2021 Jul;22(1):529. doi: 10.3892/ol.2021.12790. Epub 2021 May 16. Oncol Lett. 2021. Retraction in: Oncol Lett. 2024 Aug 05;28(4):475. doi: 10.3892/ol.2024.14608. PMID: 34055094 Free PMC article. Retracted.
-
Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis.Adv Exp Med Biol. 2021;1350:145-155. doi: 10.1007/978-3-030-83282-7_7. Adv Exp Med Biol. 2021. PMID: 34888848
-
Epigenetic modifications in follicular cell-derived thyroid cancer: new dimensions in pathogenesis and treatment.Front Oncol. 2025 May 20;15:1549477. doi: 10.3389/fonc.2025.1549477. eCollection 2025. Front Oncol. 2025. PMID: 40463874 Free PMC article. Review.
References
-
- Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7(10):569. - PubMed
-
- LiVolsi VA. Papillary thyroid carcinoma: an update. Mod Pathol. 2011;24(S2):1. - PubMed
-
- Samimi H, Fallah P, Sohi AN, Tavakoli R, Naderi M, Soleimani M, Larijani B, Haghpanah V. Precision medicine approach to anaplastic thyroid cancer: advances in targeted drug therapy based on specific signaling pathways. Acta Med Iran. 2017;55(3):200–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials